Martin P Y, Ohara M, Gines P, Xu D L, St John J, Niederberger M, Schrier R W
Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
J Clin Invest. 1998 Jan 1;101(1):235-42. doi: 10.1172/JCI626.
Normalization of the increased vascular nitric oxide (NO) generation with low doses of NG-nitro-L-arginine methyl ester (L-NAME) corrects the hemodynamic abnormalities of cirrhotic rats with ascites. We have undertaken this study to investigate the effect of the normalization of vascular NO production, as estimated by aortic cyclic guanosine monophosphate (cGMP) concentration and endothelial nitric oxide synthase (eNOS) protein expression in the aorta and mesenteric artery, on sodium and water excretion. Rats with carbon tetrachloride-induced cirrhosis and ascites were investigated using balance studies. The cirrhotic rats were separated into two groups, one receiving 0.5 mg/kg per day of L-NAME (CIR-NAME) during 7 d, whereas the other group (CIR) was administrated the same volume of vehicle. Two other groups of rats were used as controls, one group treated with L-NAME and another group receiving the same volume of vehicle. Sodium and water excretion was measured on days 0 and 7. On day 8, blood samples were collected for electrolyte and hormone measurements, and aorta and mesenteric arteries were harvested for cGMP determination and nitric oxide synthase (NOS) immunoblotting. Aortic cGMP and eNOS protein expression in the aorta and mesenteric artery were increased in CIR as compared with CIR-NAME. Both cirrhotic groups had a similar decrease in sodium excretion on day 0 (0.7 versus 0.6 mmol per day, NS) and a positive sodium balance (+0.9 versus +1.2 mmol per day, NS). On day 7, CIR-NAME rats had an increase in sodium excretion as compared with the CIR rats (sodium excretion: 2.4 versus 0.7 mmol per day, P < 0.001) and a negative sodium balance (-0.5 versus +0.8 mmol per day, P < 0.001). The excretion of a water load was also increased after L-NAME administration (from 28+/-5% to 65+/-7, P < 0.05). Plasma renin activity, aldosterone and arginine vasopressin were also significantly decreased in the CIR-NAME, as compared with the CIR rats. The results thus indicate that normalization of aortic cGMP and eNOS protein expression in vascular tissue is associated with increased sodium and water excretion in cirrhotic rats with ascites.
低剂量的N-硝基-L-精氨酸甲酯(L-NAME)使升高的血管一氧化氮(NO)生成恢复正常,可纠正肝硬化腹水大鼠的血流动力学异常。我们开展本研究以探讨血管NO生成正常化(通过主动脉环磷酸鸟苷(cGMP)浓度以及主动脉和肠系膜动脉中的内皮型一氧化氮合酶(eNOS)蛋白表达来评估)对钠和水排泄的影响。采用平衡研究对四氯化碳诱导的肝硬化腹水大鼠进行研究。将肝硬化大鼠分为两组,一组在7天内每天接受0.5 mg/kg的L-NAME(CIR-NAME),而另一组(CIR)给予相同体积的溶剂。另外两组大鼠用作对照,一组用L-NAME处理,另一组给予相同体积的溶剂。在第0天和第7天测量钠和水的排泄。在第8天,采集血样进行电解质和激素测量,并摘取主动脉和肠系膜动脉用于cGMP测定和一氧化氮合酶(NOS)免疫印迹。与CIR-NAME相比,CIR组主动脉和肠系膜动脉中的主动脉cGMP和eNOS蛋白表达增加。两个肝硬化组在第0天的钠排泄均有类似程度的降低(每天0.7对0.6 mmol,无统计学差异),且钠平衡为正值(每天+0.9对+1.2 mmol,无统计学差异)。在第7天,与CIR大鼠相比,CIR-NAME大鼠的钠排泄增加(钠排泄:每天2.4对0.7 mmol,P < 0.001),且钠平衡为负值(每天-0.5对+0.8 mmol,P < 0.001)。给予L-NAME后水负荷的排泄也增加(从28±5%增至65±7,P < 0.05)。与CIR大鼠相比,CIR-NAME组的血浆肾素活性、醛固酮和精氨酸加压素也显著降低。因此,结果表明血管组织中主动脉cGMP和eNOS蛋白表达的正常化与肝硬化腹水大鼠钠和水排泄增加有关。